A Randomized, Controlled Clinical Trial of the Safety and Efficacy of Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006595/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is a randomized, open label clinical trial to evaluate the safety and efficacy of
hydroxychloroquine (HCQ) plus usual care compared to usual care in approximately 350
hospitalized patients diagnosed with COVID-19. The study will be a 2-arm, non-blinded
comparison between open label hydroxychloroquine and usual care. The course of treatment
(HCQ) is five days. Participants will be followed to study day 28.
提供机构：
Vivli
创建时间：
2021-01-20
